Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
Clinical trial NCT03176771 · COMPLETED
Trial details
- NCT number
- NCT03176771
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2020-09-29
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.